Searched for
PIRAMAL PHARMA REVENUE
Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal Manchanda- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 27% in 1 year
- Q4 earnings roundup: Raymond Realty, MCX among 19 companies that delivered 100%+ growth in sales and PAT
- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...20 May, 2026, 12.05 PM IST
- Smallcaps & midcaps rally! Firstsource Solutions, Nuvama, Godfrey Phillips, other stocks jump up to 16%Smallcap and midcap stocks outperformed benchmarks on Friday, with select names rallying up to 16% despite broader market weakness. Gains w...08 May, 2026, 12.50 PM IST
- Small & midcaps rally! Wockhardt, Coforge, other stocks surge up to 14%. Do you own any?Smallcap and midcap stocks surged on Wednesday, outperforming broader market indices with gains of around 1% each. This rally was fueled by...06 May, 2026, 11.56 AM IST
- Nandini Piramal warns prolonged West Asia war may raise input costsGeopolitical tensions in West Asia are manageable now. However, a prolonged US-Israel war against Iran could raise costs for petrochemical-...29 Apr, 2026, 10.01 PM IST
- Piramal Pharma deploying USD 85 mn capex this fiscal: Nandini PiramalPiramal Pharma is investing USD 85 million this fiscal for initiatives like capacity expansion and maintenance. They have already used USD ...27 Oct, 2024, 11.48 AM IST
- Piramal Pharma targets to double revenue in 5 yearsPiramal Pharma aims to achieve $2 billion in annual revenue with a 25% operating margin by fiscal 2030, driven by its CDMO business. The co...25 Sep, 2024, 11.32 PM IST
- Piramal Pharma Q1 Results: Net loss narrows to Rs 89 crorePiramal Pharma Q1 Earnings: Piramal Pharma narrowed its net loss to Rs 89 crore in Q1FY25 from a net loss of Rs 99 crore in the correspondi...26 Jul, 2024, 05.53 PM IST
- Fundamental Radar: Why does Piramal Pharma stock deserve a re-rating? Sandeep Raina explainsThe company witnessed multiple challenges related to macroeconomic factors during and after COVID-19, high attrition at European manufactur...27 Feb, 2024, 10.00 AM IST
- After a tough year, Piramal Pharma hopes to regain vigour in 2nd halfPiramal Pharma chairperson Nandini Piramal in an interview to ET said the company is aiming for mid-teen revenue growth and a meaningful im...07 Nov, 2023, 11.31 PM IST
- Pickup in contract manufacturing biz set to drive growth: Piramal Pharma"During the year (FY23), the customer decision-making got delayed due to macro-economic environment and pipeline prioritisation based on li...01 Aug, 2023, 12.20 AM IST
- Piramal Pharma stock rises over 3%. Here’s whyThe brokerage firm Jefferies assigned buy rating to Piramal Pharma with a target price of Rs 150, implying an upside potential of 20% from ...03 Jan, 2023, 11.08 AM IST
- Piramal Pharma to inject funds into expansion, acquisitionsPiramal Pharma received a $360 million investment from US private equity company Carlyle Group in October 2020 in exchange for a 20% share....25 Oct, 2022, 04.18 AM IST
- Piramal Pharma in talks for $225 million offshore loansAt least three top lenders - Axis Bank, HSBC and State Bank of India (SBI) - are likely to extend the loan, which could be raised in the Gu...13 Sep, 2022, 04.52 AM IST
- Piramal shares to trade ex-demerger on TuesdayPiramal Enterprises has secured the approval of the National Company Law Tribunal (NCLT) for the demerger of its pharmaceutical business an...30 Aug, 2022, 09.28 AM IST
- Piramal Enterprise gets board nod for demerger and listing of pharma businessThe pharmaceuticals business will get vertically demerged from Piramal Enterprises and consolidated under Piramal Pharma Ltd (PPL), the gro...07 Oct, 2021, 10.16 PM IST
- DHFL aside, pharma to drive Piramal stockThe company’s management has guided for a 15 per cent organic revenue growth in the pharma business for FY22 compared with the 1 per cent g...04 Mar, 2021, 08.52 AM IST
- Can pharma business once again turn Ajay Piramal's fortune?The business house controls both the business segments through a listed entity Piramal Enterprises.31 Aug, 2020, 09.44 PM IST
Load More
